HR 6077
HEAL-AI Act
TL;DR
Rep. Nanette Barragán's HEAL-AI Act (HR 6077) directs federal health agencies to study how AI is used in healthcare, focusing on patient safety, bias, privacy, and clinical decision-making. It's an information-gathering bill at this stage, not a regulatory mandate, and sits in the House Energy and Commerce Committee.
How This Might Impact Your Business
Healthcare AI vendors (diagnostic tools, clinical decision support, patient triage) would face federal scrutiny of how their algorithms are trained, validated, and monitored.
Hospitals and health systems using AI for care decisions could see findings that eventually shape reimbursement, HIPAA guidance, or FDA oversight.
Health insurers using AI for claims processing, prior authorization, or coverage decisions would likely be examined for bias against protected populations.
No immediate compliance requirements, penalties, or deadlines for private companies; the bill primarily tasks HHS with producing reports and recommendations.
Digital health startups and telehealth platforms should expect the resulting reports to inform future rulemaking within 1-2 years.
Findings could specifically target algorithmic bias in maternal health, minority patient outcomes, and underserved communities given the sponsor's policy focus.
Pharmaceutical and medical device companies using AI in drug discovery or device software (SaMD) may see downstream FDA guidance shifts.
What Should You Do
Inventory every AI or algorithmic tool currently used in your clinical, claims, or patient-facing workflows and document the training data, validation methods, and bias testing behind each.
Ask your compliance and legal teams to draft a position on algorithmic transparency now, before HHS recommendations create a reactive scramble.
Assign someone to track this bill through House Energy and Commerce; sign up for committee alerts and watch for a subcommittee hearing.
Benchmark your bias auditing practices against existing frameworks (NIST AI RMF, FDA's Good Machine Learning Practice) so you're ahead of any resulting rules.
If you sell AI to hospitals or payers, prepare customer-facing documentation on model performance across demographic groups; procurement teams will start asking.
Who It Affects
Sponsors
Status Timeline
committee
Referred to the House Committee on Energy and Commerce.
November 18, 2025